![Tobin Juvenal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tobin Juvenal
Corporate Officer/Principal bei
CASTLE BIOSCIENCES, INC.
Vermögen: 2 Mio $ am 31.07.2026
Profil
Tobin W.
Juvenal is currently Chief Commercial Officer at Castle Biosciences, Inc., a position held since 2020, with employment at the company starting in 2008.
Former positions include Director & Manager-District Sales at AstraZeneca LP, Vice President-Sales at Encysive Pharmaceuticals, Inc. in 2007, Manager-Area Sales at deCODE genetics, Inc., and Vice President-Sales at Genzyme Pharmaceuticals, Inc. Education includes undergraduate studies at the University of Florida.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CASTLE BIOSCIENCES, INC. 0,25 % | 17.08.2026 | 77.265 ( 0,25 % ) | 2 Mio $ | 31.07.2026 |
Aktive Positionen von Tobin Juvenal
| Unternehmen | Position | Beginn |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Corporate Officer/Principal | 01.08.2020 |
Ehemalige bekannte Positionen von Tobin Juvenal
| Unternehmen | Position | Ende |
|---|---|---|
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Vertrieb & Marketing | 01.01.2007 |
Genzyme Pharmaceuticals, Inc.
 Genzyme Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical materials and drug delivery technologies | Vertrieb & Marketing | - |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Direktor/Vorstandsmitglied | - |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company | Vertrieb & Marketing | - |
Ausbildung von Tobin Juvenal
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
44
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Health Technology |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company | Health Technology |
Castle Biosciences, Inc.
 Castle Biosciences, Inc. Medical SpecialtiesHealth Technology Operates dermatological cancer company which provides clinically actionable genomic information to make accurate treatment decisions | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Pharmaceuticals, Inc.
Genzyme Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical materials and drug delivery technologies | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
